Heres Why Exelixis Stock Is Dropping Today – Motley Fool

What happened
Shares of Exelixis(NASDAQ:EXEL), an oncology-focused biopharmaceutical company, started sliding Monday in response to a disappointing clinical trial readout. Investors responding to re… [+1965 chars]